APOE and early-onset autosomal dominant Alzheimer disease: Our proposed method offers a less invasive and more straightforward means of detecting Aβ42 and ApoE4 in human plasma, enabling the monitoring of Alzheimer’s disease progression, particularly in elderly patients.